GlucoTrack (NASDAQ:GCTK – Get Free Report) and Varex Imaging (NASDAQ:VREX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.
Profitability
This table compares GlucoTrack and Varex Imaging’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| GlucoTrack | N/A | -2,311.96% | -264.11% |
| Varex Imaging | -8.32% | 7.19% | 3.06% |
Volatility & Risk
GlucoTrack has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500. Comparatively, Varex Imaging has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500.
Institutional & Insider Ownership
Analyst Ratings
This is a breakdown of recent ratings and target prices for GlucoTrack and Varex Imaging, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GlucoTrack | 1 | 0 | 0 | 0 | 1.00 |
| Varex Imaging | 1 | 1 | 2 | 0 | 2.25 |
Varex Imaging has a consensus price target of $16.17, suggesting a potential upside of 16.06%. Given Varex Imaging’s stronger consensus rating and higher probable upside, analysts plainly believe Varex Imaging is more favorable than GlucoTrack.
Valuation & Earnings
This table compares GlucoTrack and Varex Imaging”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| GlucoTrack | N/A | N/A | -$22.60 million | ($34.62) | -0.05 |
| Varex Imaging | $844.60 million | 0.69 | -$70.30 million | ($1.70) | -8.19 |
GlucoTrack has higher earnings, but lower revenue than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks.
Summary
Varex Imaging beats GlucoTrack on 9 of the 13 factors compared between the two stocks.
About GlucoTrack
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
About Varex Imaging
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.
